Leveraging AI and ML in Drug R&D: Current and Future Impacts to the Life Sciences Industry

LifeSci Search Podcast: Episode #1

Regenerative Medicine from Humacyte: Off-the-Shelf, Human-Sourced Acellular Vessels for Traumatic Wound Repair

A Brief Chat with Erez Raphael, CEO of DarioHealth

Onconova – Developing Best-in-class Anti-cancer Agents with Multi-faceted MOAs

A Brief Chat with Dror Bashan, President & CEO of Protalix Biotherapeutics, Inc.

A Brief Chat with Martin Welschof, CEO of BioInvent

A Brief Chat with Raphi Levy, CFO of Alpha Tau Medical Ltd.

A Brief Chat with Amir London, CEO of Kamada Ltd.

A Brief Chat with Rob Etherington, President & CEO of Clene, Inc.

Helping the Body Help Itself with EscharEx: The Next Generation Wound-Care Therapeutic from MediWound

A Promising New Immune Checkpoint from Sensei Bio: VISTA

Turning Amino Acids into Drugs: A Novel Platform from Axcella Health

Lipocine Inc’s Formulation for Success: Oral Agents for CNS Disorders

89bio Aims to Tame NASH and Severe Hypertriglyceridemia (SHTG) with Lead Asset Pegozafermin

De-Risked Oncology Targets with Assets from Checkpoint Therapeutics

Deep Transcranial Magnetic Stimulation (Deep TMS™): BrainsWay’s Innovative and Non-Invasive Therapy for Major Depressive Disorder, Anxious Depression, OCD, and Smoking Addiction

An Oncology Update on CDK 2/9 Inhibition: Cyclacel Pharmaceuticals

Oncology on the Move—Artios: Financing Considerations for an Early Biotech

Fire Up the Immune System to Lead the Charge Against Cancer: Alligator Bioscience